AmberGen’s state-of-the-art MALDI Imaging facility provides label-free drug screening services based on its patented revolutionary Bead-AMS™ proteomic technology. This approach is especially useful to identify on and off-target hits against a library of proteins such as the kinome and can provide information about potential adverse drug side-effects and drug repurposing. Contact us to learn more.
Development of High-throughput, Accurate, Multiplex Immuno-Diagnostic Assays
AmberGen provides services to develop custom immunodiagnostics which incorporate our proprietary PC-PURE™ technology and bead-based automation methodology for gold-standard diagnostic performance and industry-leading throughput. Contact us to learn more.
Mass Spectrometric Imaging
AmberGen offers in-house mass spectrometric imaging services for advanced tissue and array scanning using state-of-the-art instruments and methodology to suit your research needs. Our experts will work with you to provide optimal research solutions. Contact us to learn more.
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- AmberGen receives US Patent 9,910,034 increasing its broad coverage on PC-PURE™ photo-affinity biomarker purification and enrichment technology for improving the accuracy of diagnostic testing March 2018
- Paper published in PLOS ONE in collaboration with Boston Children’s Hospital “Photocleavage-based affinity purification of biomarkers from serum: Application to multiplex allergy testing” describing application of AmberGen’s PC-PURE™ to highly multiplex in vitro allergy testing (AllerBead™) February 2018